Charles River Laboratories (CRL)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	227,347	527,956	562,053	575,346	617,261	648,149	647,623	670,089	650,975	659,972	664,798	614,937	589,862	545,982	522,933	462,151	432,729	412,591	372,640	375,640
Revenue (ttm)	US$ in thousands	4,086,133	4,070,653	4,059,413	4,065,363	4,086,910	4,314,900	4,293,342	4,227,890	4,106,274	3,792,022	3,683,743	3,605,712	3,459,843	3,333,185	3,172,755	2,930,880	2,859,828	2,759,976	2,697,739	2,671,095
Operating profit margin		5.56%	12.97%	13.85%	14.15%	15.10%	15.02%	15.08%	15.85%	15.85%	17.40%	18.05%	17.05%	17.05%	16.38%	16.48%	15.77%	15.13%	14.95%	13.81%	14.06%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $227,347K ÷ $4,086,133K
= 5.56%

Charles River Laboratories' operating profit margin has shown fluctuations over the years. It improved from 14.06% on March 31, 2020, to a peak of 18.05% on June 30, 2022. Subsequently, there was a slight decline in the operating profit margin, reaching 12.97% on September 30, 2024, before dropping significantly to 5.56% on December 31, 2024.

The company experienced relatively stable operating margins between 2020 and 2022, indicating efficient cost management and revenue generation. However, there was a notable decline in profitability in the last two quarters of 2024, potentially signaling challenges in controlling costs or generating sufficient revenue.

Overall, while Charles River Laboratories has shown periods of strong operating profit margins, the recent significant decrease highlights the importance of analyzing the underlying factors affecting profitability to ensure sustained financial performance.